CLINICAL_TRIALS
trial_result
· 2021-10-22
Clinical Trial Update: Propranolol Dose Escalation in Lymphedema in Patients [Phase 2]
Summary
Phase 2 trial update on propranolol dose escalation for primary lymphedema; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Columbia University | Conditions: Primary Lymphedema | Phase 2 | Status: TERMINATED | Results posted: 2021-10-22